IEEE Open Journal of Engineering in Medicine and Biology,
Journal Year:
2020,
Volume and Issue:
1, P. 243 - 248
Published: Jan. 1, 2020
Goal:
The
aim
of
the
study
herein
reported
was
to
review
mobile
health
(mHealth)
technologies
and
explore
their
use
monitor
mitigate
effects
COVID-19
pandemic.
Methods:
A
Task
Force
assembled
by
recruiting
individuals
with
expertise
in
electronic
Patient-Reported
Outcomes
(ePRO),
wearable
sensors,
digital
contact
tracing
technologies.
Its
members
collected
discussed
available
information
summarized
it
a
series
reports.
Results:
identified
that
could
be
deployed
response
pandemic
would
likely
suitable
for
future
pandemics.
Criteria
evaluation
were
agreed
upon
applied
these
systems.
Conclusions:
mHealth
are
viable
options
patients
used
predict
symptom
escalation
earlier
intervention.
These
also
utilized
who
presumed
non-infected
enable
prediction
exposure
SARS-CoV-2,
thus
facilitating
prioritization
diagnostic
testing.
BMJ,
Journal Year:
2020,
Volume and Issue:
unknown, P. m3026 - m3026
Published: Aug. 11, 2020
What
you
need
to
know•
Management
of
covid-19
after
the
first
three
weeks
is
currently
based
on
limited
evidence
•
Approximately
10%
people
experience
prolonged
illness
Many
such
patients
recover
spontaneously
(if
slowly)
with
holistic
support,
rest,
symptomatic
treatment,
and
gradual
increase
in
activity
Home
pulse
oximetry
can
be
helpful
monitoring
breathlessness
Indications
for
specialist
assessment
include
clinical
concern
along
respiratory,
cardiac,
or
neurological
symptoms
that
are
new,
persistent,
progressive
PLoS ONE,
Journal Year:
2021,
Volume and Issue:
16(3), P. e0247461 - e0247461
Published: March 4, 2021
Aim
COVID-19
clinical
presentation
is
heterogeneous,
ranging
from
asymptomatic
to
severe
cases.
While
there
are
a
number
of
early
publications
relating
risk
factors
for
infection,
low
sample
size
and
heterogeneity
in
study
design
impacted
consolidation
findings.
There
pressing
need
identify
the
which
predispose
patients
cases
COVID-19.
For
rapid
widespread
stratification,
these
should
be
easily
obtainable,
inexpensive,
avoid
invasive
procedures.
The
aim
our
fill
this
knowledge
gap
by
systematically
mapping
all
available
evidence
on
association
various
clinical,
demographic,
lifestyle
variables
with
specific
adverse
outcomes
Methods
systematic
review
was
conducted
using
standardized
methodology,
searching
two
electronic
databases
(PubMed
SCOPUS)
relevant
literature
published
between
1
st
January
2020
9
th
July
2020.
Included
studies
reported
characteristics
while
reporting
disease
severity.
In
case
sufficient
comparable
data,
meta-analyses
were
estimate
each
variable.
Results
Seventy-six
identified,
total
17,860,001
across
14
countries.
highly
heterogeneous
terms
under
study,
outcomes,
measures
reported.
A
large
presented
Commonly
outcome
comprised
patient
characteristics,
including
age
>75
(OR:
2.65,
95%
CI:
1.81–3.90),
male
sex
2.05,
1.39–3.04)
obesity
2.57,
1.31–5.05).
Active
cancer
1.46,
1.04–2.04)
associated
increased
outcome.
common
symptoms
vital
(respiratory
rate
SpO2)
also
suggested
elevated
profiles.
Conclusions
Based
findings
range
assessed
parameters
valuable
predict
illness
mortality
as
result
COVID-19,
detailed
comorbidities,
alongside
novel
inclusion
real-time
measurements.
Pain,
Journal Year:
2020,
Volume and Issue:
161(8), P. 1694 - 1697
Published: June 3, 2020
1.
Introduction
The
COVID-19
pandemic
has
impacted
the
lives
and
health
of
persons
worldwide,
with
potential
for
further
effects
in
future.
experience
living
within
this
disrupted
daily
life
across
all
sectors,
including
those
chronic
pain
(CP),
infected
coronavirus
Severe
Acute
Respiratory
Syndrome
(SARS)-CoV2,
healthcare
providers
essential
workers,
as
well
who
remained
physically
healthy.
toll
extends
beyond
physical
illness,
important
psychosocial
stressors
that
include
prolonged
periods
limited
interpersonal
contact,
isolation,
fear
future
uncertainty,
financial
strain.
Uncertainty
is
fuelled
by
constant
media
coverage,
often
conflicting
information,
differing
recommendations
public
authorities
different
jurisdictions,
unknown
duration
likelihood
resurgence
pandemic.
In
context,
we
will
examine
consequences
germane
to
CP,
which
might
be
nociplastic,
neuropathic,
or
nociceptive.
Specific
possibilities
include:
(1)
CP
part
a
postviral
syndrome
result
viral-associated
organ
damage;
(2)
worsening
due
exacerbation
preexisting
mental
complaints;
(3)
newly
triggered
individuals
not
COVID
risk
factors
(poor
sleep,
inactivity,
fear,
anxiety,
depression).
Chronic
must
considered
context
biopsychosocial
model,
views
symptoms
complex
dynamic
interaction
between
biological,
psychological,
social
factors.36,39
Underlying
predisposing
mechanisms
genetic
factors,
previous
experience,
traumatic
events
could
emotional.2
conditions
can
organ-specific
biological
may
preferentially
occur
fragile
stress
response
system.8,10,24,40,47
many
characteristics
potentially
increase
prevalence
especially
extending
over
months.
worldwide
community
invited
consider
possible
downstream
COVID-19,
only
patients
surviving
infection,
but
also
wider
experienced
social,
economic
effects.
Although
address
these
issues
from
perspective
physicians
practicing
developed
countries,
discussed
particularly
relevant
people
other
call
colleagues
Asia,
Africa,
South
America
enter
into
dialogue.
2.
Infections
trigger
viral
illnesses
present
myalgia
fatigue,
symptoms,
seen
influenza,
noted
H1N1
pandemics
1918
2009,
infection
during
SARS
epidemic.4,17
Outcomes
related
infections
are
almost
always
focused
on
immediate
acute
little
attention
long-term
outcomes.
small
study
22
subjects
(21
whom
were
workers)
epidemic,
post-SARS
consisting
diffuse
myalgia,
depression,
nonrestorative
sleep
persisted
2
years.27
Similarly,
some
widespread
report
onset
after
perceived
illness.
cause
specific
postinfectious
syndromes,
there
common
stereotypical
any
type
observed.
For
example,
up
12%
3
pathogens,
ie,
Ross
River
virus
(the
epidemic
polyarthritis),
Coxiella
burnetii
(cause
Q
fever),
Epstein–Barr
virus,
pain,
memory
difficulties
12
months
infection.15
have
markedly
disparate
presentations,
occurred
at
remarkably
similar
rates
was
predicted
demographic,
psychological/psychiatric
measures,
microbiological
factors.15
presence
severity
somatic
closely
correlated
subsequent
development
fatigue
pain.
regional
follow
types
infection.
meta-analysis,
Halvorson
et
al.
approximately
10%
develop
irritable
bowel
an
episode
bacterial
gastroenteritis,
premorbid
psychological
problems
and/or
recognized
factors.7,13
On
note,
urinary
tract
evident
substantial
proportion
women
interstitial
cystitis/painful
bladder
syndrome.43
Collectively,
findings
imply
various
capable
triggering
both
CP.
evidence
suggests
inciting
sufficient
disrupt
normal
activities.44
Current
estimates
80%
laboratory-confirmed
mild
moderate
disease,
pneumonia
nonpneumonia
cases,
13.8%
severe
6.1%
critical
illness
requiring
intensive
care
unit
(ICU)
admission.42
3.
Potential
health-related
3.1.
consequence
disease
Persons
exhibit
broad
range
beginning
asymptomatic
full-blown
respiratory
distress
syndrome.
Nonspecific
constitutional
myalgias,
chills,
headaches.
Most
1
weeks
complete
resolution,
although
require
hospitalization.
mortality
rate
order
1%
according
published
Centre
Evidence-Based
Medicine.37
Whether
more
susceptible
thereof
unknown.
Theoretically,
diminished
immune
system
observed
even
suppressed
such
poor
opioid
use,
susceptibility
SARS-CoV2.19,41
Many
need
ICU
care,
admission
increased
long-lasting
functional
limitations,
distress,
Surveys
reported
persistent
38%
56%
survivors
when
evaluated
4
years
admission.18,34
Quality
affected
periods.
evaluating
575
6
11
discharge,
difficulty
mobility
(52%),
self-care
(19%),
activities
pain/discomfort
(57%),
cognition
(43%).38
Mental
frequently
Between
41%
65%
symptoms.20,23
25%
44%
Hong
Kong
residents
survived
diagnosed
posttraumatic
disorder
(PTSD),
15%
depression
least
30
illness.16,22
Posttraumatic
40.7%
SARS-infected
workers.22
3.2.
Exacerbation
absence
actual
Some
resulting
personal
issues.
Regular
medical
compromised
lockdown
ensuing
months.9
Routine
clinics
less
accessible
closed,
professionals
diverted
COVID-19-related
activities,
waiting
times
prolonged,
nonurgent.
Patients
able
willing
travel
fearful
exposure
setting.
There
delays
timely
access
medications
reduced
prescribing,
management
procedures
lesser
importance
than
urgent
illnesses.
Reduced
clinical
encounters
interdisciplinary
team
members
(eg,
physiotherapists,
psychologists,
self-help
groups)
adverse
consequences.
Access
logistical
true
drug
shortages
analgesic
emergency
causing
turn
alcohol
nonmedically
prescribed
substances
desperate
measure
relieve
poorly
managed
rapid
evolution
telehealth
presents
new
challenges
fully
comfortable
without
digital
technology.
impact
working
lost
jobs
insurance
contend
insecurity
poverty.
Another
factor
vital
strategy
distancing
closure
group
activity
programs
gyms
pools.21
Limited
support
contribute
health.12
heightened
awareness
accompanied
indication
These
numerous
exacerbate
Given
wisdom
suggest
catastrophic
stressful
inevitably
lead
However,
studies
performed
United
States
just
before
9/11
terrorist
attacks
indicate
Pain
complaints
did
change
among
New
York
Jersey
had
been
surveyed
World
Trade
Center.32
fibromyalgia
Washington,
D.C.
region
same
period.32
Daily
"hassles"
personally
seem
likely
major
do
individual.30
Therefore,
(ie,
current
pandemic),
vocational
uncertainty
loss
jobs,
adversely
affecting
Reviews
highlight
role
number
intensity
"stressor"
predicting
Female
sex,
concerns
about
expectation
chronicity,
inactivity
time
off
work
symptoms.26
Naturally
occurring
earthquakes,
floods,
fires
similarly
"man-made"
chemical
spills
war.6
Exposure
multitude
simultaneously,
time,
pose
significant
later
sequelae.14,33
military
personnel,
multiple
deployments
significantly
PTSD
psychiatric
conditions,
highly
coprevalent
CP.46
3.3.
It
currently
known
whether
new-onset
population
large.
Risk
longitudinal
studied
temporomandibular
disorders.11,25,29
thought
consistently
shown
high
baseline
levels
modestly
(OR
1.5-2).25
Regional
female
low
socioeconomic
status
strongest
predictors
pain.11,25
Other
activity.
Sleep
deprivation
virtually
indistinguishable
tenderness.28
Furthermore,
attenuated
remain
active
sensitive
disruption).1
Healthcare
workers
recent
Israeli
study,
9.7%
cohort
206
nurses
fulfilled
criteria
fibromyalgia,
strongly
work-related
PTSD-related
symptoms.3
Numerous
geographic
boundaries.
Nearly
everyone
exposed
relentless
coverage
messages,
contracting
SARS-CoV2,
routine
family,
pervasive.
Those
underlying
particular
exacerbation.
Further
relate
distancing,
isolation
quarantine,
some,
grieving
death
usual
system.
Persistent
extreme
suicide
rate.
preliminary
anxiety
(16%-28%),
self-reported
(8%),
disturbances
reactions
pandemic.31
During
outbreak
2003,
historically
18.6
per
100,000
Kong.5
annual
older
adults
return
preepidemic
levels,
suggesting
4.
Immediate
strategies
mitigate
Recovery
life-threatening
expected
affect
health.
Rehabilitation
services
should
mobilized
inpatient
outpatient
paid
staffing
ensure
services,
physiotherapy,
occupational
therapy.35
resume
most
patients,
flexible
adapt
methods
delivery,
regard
telemedicine.9
communicating
emphasis
virtual
learning
teaching.
attuned
hardship,
substance
abuse,
domestic
violence,
suicide.
Providers
low-
middle-income
countries
disadvantaged
resources
shortage
workers.45
Developed
recognize
crises
underdeveloped
constrained
artificial
boundaries
continue
participate
efforts
led
international
organizations
Health
Organization
International
Red
Cross.
suggestions
implemented
if
governments
legislators
partnership
accordance
experts.
5.
Conclusion
unprecedented
crisis,
directed
towards
containment
patient
care.
manifested
spared
nevertheless
disruptions
wide
array
physical,
stressors.
Based
past
postulate
scenarios
collectively
possibly
Amidst
uncertainties,
research
urged
devise,
implement
aimed
mitigating
pain-related
establishment
registries
(including
concomitant
CP),
designated
follow-up
persons,
examination
means
delivering
surveys
gather
information
COVID-19.
Epidemiological
data
used
inform
policies
seek
reduce
magnitude
epidemics
their
myriad
diseases.
recognition
exacerbations
prompt
targeted
treatment,
encouraged.
Conflict
interest
statement
D.J.
Clauw
consulting
Pfizer,
Tonix,
Samumed,
Lilly,
Aptinyx,
received
funding
Aptinyx.
S.P.
Cohen
supported
grant
U.S.
Dept.
Defense,
Uniformed
Services
University,
Department
Physical
Medicine
&
Rehabilitation,
Musculoskeletal
Injury
Research
Operational
Readiness
(MIRROR)
(HU00011920011).
remaining
authors
no
conflicts
declare.
Frontiers in Medicine,
Journal Year:
2020,
Volume and Issue:
7
Published: Dec. 3, 2020
The
explosion
of
the
new
coronavirus
(SARS-CoV-2)
pandemic
has
brought
role
angiotensin
converting
enzyme
2
(ACE2)
back
into
scientific
limelight.
Since
SARS-CoV-2
must
bind
ACE2
for
entering
host
cells
in
humans,
its
expression
and
body
localization
are
critical
to
track
potential
target
organ
this
infection
outline
disease
progression
clinical
outcomes.
Here,
we
mapped
physiological
distribution,
expression,
activities
discussed
correlations
mutal
interactions
with
disparate
symptoms
present
patients
at
level
different
organs.
We
highlighted
that
despite
during
ACE2-expressing
organs
may
become
direct
targets,
leading
severe
pathological
manifestations,
subsequent
multiple
failures,
exact
mechanism
through
which
acts
these
is
still
heavily
debated.
Further
efforts,
also
considering
a
personalized
approach
aimed
consider
specific
patient
differences
mutual
ACE2-SARS-CoV-2
long-term
health
effects
associated
COVID-19
currently
mandatory.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2020,
Volume and Issue:
unknown
Published: Oct. 21, 2020
Reports
of
“Long-COVID”,
are
rising
but
little
is
known
about
prevalence,
risk
factors,
or
whether
it
possible
to
predict
a
protracted
course
early
in
the
disease.
We
analysed
data
from
4182
incident
cases
COVID-19
who
logged
their
symptoms
prospectively
COVID
Symptom
Study
app.
558
(13.3%)
had
lasting
>=28
days,
189
(4.5%)
for
>=8
weeks
and
95
(2.3%)
>=12
weeks.
Long-COVID
was
characterised
by
fatigue,
headache,
dyspnoea
anosmia
more
likely
with
increasing
age,
BMI
female
sex.
Experiencing
than
five
during
first
week
illness
associated
Long-COVID,
OR=3.53
[2.76;4.50].
A
simple
model
distinguish
between
short
long-COVID
at
7
which
gained
ROC-AUC
76%,
replicated
an
independent
sample
2472
antibody
positive
individuals.
This
could
be
used
identify
individuals
clinical
trials
reduce
long-term
target
education
rehabilitation
services.
Journal of Infection,
Journal Year:
2021,
Volume and Issue:
83(1), P. 1 - 16
Published: May 14, 2021
"Long
COVID",
a
term
coined
by
COVID-19
survivors,
describes
persistent
or
new
symptoms
in
subset
of
patients
who
have
recovered
from
acute
illness.
Globally,
the
population
people
infected
with
SARS-CoV-2
continues
to
expand
rapidly,
necessitating
need
for
more
thorough
understanding
array
potential
sequelae
COVID-19.
The
multisystemic
aspects
been
subject
intense
investigation,
but
long-term
complications
remain
poorly
understood.
Emerging
data
lay
press,
social
media,
commentaries,
and
emerging
scientific
reports
suggest
that
some
survivors
experience
organ
impairment
and/or
debilitating
chronic
symptoms,
at
times
protean
nature,
which
impact
their
quality
life.
Biomedicines,
Journal Year:
2021,
Volume and Issue:
9(8), P. 966 - 966
Published: Aug. 5, 2021
The
majority
of
people
infected
with
SARS-CoV-2
fully
recovered
within
a
few
weeks.
However,
considerable
number
patients
different
ages
still
suffer
from
long-lasting
problems
similar
to
the
multi-organ
damage
in
its
acute
phase
infection,
or
experience
symptoms
continuously
for
longer
term
after
recovery.
severity
primary
infection
seems
not
be
associated
possibility
and
long-term
symptoms.
Various
unresolved
have
been
reported
COVID-19
survivors
months
hospital
discharge.
Long
Syndrome
refers
4
initial
onset.
It
is
important
understand
systemic
effects
Syndrome,
presentations,
need
rehabilitations
restore
functional
recovery
survivors.
Government,
healthcare
workers,
survivor
groups
should
collaborate
establish
self-sustaining
system
facilitate
follow-up
rehabilitations,
prioritization
resources
more
severely
This
review
looks
into
various
aspects:
respiratory,
cardiovascular,
hematological,
renal,
gastrointestinal,
neurological,
metabolic
Syndromes.
Recommendations
details
explored
cope
tremendous
patients.
Milbank Quarterly,
Journal Year:
2021,
Volume and Issue:
99(2), P. 519 - 541
Published: March 30, 2021
Policy
Points
An
estimated
700,000
people
in
the
United
States
have
"long
COVID,"
that
is,
symptoms
of
COVID-19
persisting
beyond
three
weeks.
and
its
long-term
sequelae
are
strongly
influenced
by
social
determinants
such
as
poverty
structural
inequalities
racism
discrimination.
Primary
care
providers
a
unique
position
to
provide
coordinate
for
vulnerable
patients
with
long
COVID.
measures
should
include
strengthening
primary
care,
optimizing
data
quality,
addressing
multiple
nested
domains
inequity.